중동 및 아프리카 멀티플렉스 분석 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 중동 및 아프리카 멀티플렉스 분석 시장

멀티플렉스 검사 시장은 2021년부터 2028년까지의 예측 기간 동안 6.5%의 시장 성장을 목격할 것으로 예상됩니다. 멀티플렉스 검사 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 의료 분야의 성장은 멀티플렉스 검사 시장의 성장을 가속화하고 있습니다.

멀티플렉스 분석은 단일 샘플에서 여러 분석물을 결정하기 위해 자기 비드 또는 비자성 비드를 사용하는 면역 분석 유형을 말합니다. 멀티플렉스 분석은 ELISA와 유사한 것으로 간주되지만, 여기 멀티플렉스 분석에서는 캡처 항체를 결합하는 데 매우 유익한 비드가 있습니다.

이 지역의 여성 유방암 유병률 증가는 멀티플렉스 검사 시장 성장을 견인하는 주요 요인 중 하나로 작용합니다. 사우디 질병 예방 및 통제 센터가 의료 시설을 대상으로 코로나바이러스 PCR 검사 프로그램을 시작하고 멀티플렉스 PCR을 광범위하게 적용하여 진단 프로세스를 개선하면서 시장 성장이 가속화되었습니다. 동반 진단에서 멀티플렉스 검사의 높은 사용과 싱글플렉스 및 기존 검사에 비해 유리한 기술 채택 증가는 시장에 더 큰 영향을 미칩니다. 또한 투자 급증, 의료비 급증 , 노인 인구 증가, 인식 증가는 멀티플렉스 검사 시장에 긍정적인 영향을 미칩니다. 나아가 고처리량 및 자동화 시스템에 대한 필요성과 분자 및 단백질 진단에서 바이오마커 검증 증가는 2021년에서 2028년 사이의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

반면, 장비와 관련된 높은 비용은 시장 성장을 방해할 것으로 예상됩니다. 엄격한 규정과 표준의 존재는 2021-2028년 예측 기간에 멀티플렉스 분석 시장에 도전할 것으로 예상됩니다.

This multiplex assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Middle East and Africa Multiplex Assays Market Scope and Market Size

The multiplex assays market is segmented on the basis of products & services, type, technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of product & services, the multiplex assays market is segmented into reagents & consumables, instruments & accessories and software and services.
• On the basis of type, the multiplex assays market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.
• On the basis of technology, the multiplex assays market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others.
• On the basis of application, the multiplex assays market is segmented into research & development and clinical diagnostics. Research & development is sub-segmented into drug discovery & development and biomarker discovery & validation. Clinical diagnostics is sub-segmented into infectious diseases, cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, allergies, nervous system disorders, metabolism & endocrinology disorders and others.
• On the basis of end user, the multiplex assays market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.

Middle East and Africa Multiplex Assays Market Country Level Analysis

The multiplex assays market is analyzed and market size insights and trends are provided by country, products & services, type, technology, application and end user as referenced above.      

The countries covered in the Middle East and Africa multiplex assays market report are Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.

Saudi Arabia dominates the Middle East and Africa multiplex assays market due to the increase in prevalence of breast cancer within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

Middle East and Africa multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa multiplex assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Middle East and Africa multiplex assays market. The data is available for historic period 2010-2019.

Competitive Landscape and Middle East and Africa Multiplex Assays Market Share Analysis

The multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to multiplex assays market.

The major players covered in the multiplex assays market report are BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens AG, Hologic Inc., Luminex Corporation. , MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc. , Illumina, Inc. , AGENA BIOSCIENCE, INC. , Olink , Randox Laboratories Ltd., Bio-Techne. , Agilent Technologies, Agilent Technologies, Sysmex Corporation, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-27509